About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Phoenix | 176 Studies

Clinical Trials HypertensionPhoenix

Hypertension Clinical Trials in Phoenix

Find 176 clinical trials for hypertension near Phoenix, Arizona. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 176 trials

CompletedA Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesThe aim of this study is to evaluate the efficacy of VRB-101 for body weight reduction compared to placebo in participants who have obesity or overweight with weight-related…NCT07281937·Anniston, Alabama and 21 others UnknowniStent Inject New Enrollment Post-Approval StudyStudy to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.NCT04624698·Phoenix, Arizona and 2 others Active not recruitingOpen-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionThis study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypertensionNCT05968430·Birmingham, Alabama and 176 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionThe main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.NCT05147805·Phoenix, Arizona and 91 others

TerminatedStudy of Cicletanine for Pulmonary Arterial Hypertension (PAH)This Phase 2, randomized, double-blind, placebo-controlled, multicenter, dose-ranging study will compare the efficacy, safety, and tolerability of cicletanine hydrochloride (HCl)…NCT00832507·Mobile, Alabama and 55 others

CompletedEfficacy Study of Digibind for Treatment of Severe PreeclampsiaThe purpose of this study is to determine whether a commercially available anti-digoxin antibody, Digibind, can delay delivery in patients with severe pre-eclampsia.NCT00158743·Mobile, Alabama and 7 others

CompletedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 StudyThis is a Phase III, randomized, double-masked, active-controlled, parallel-group, multi-center study.NCT03691649·Phoenix, Arizona and 46 others

CompletedThe Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting GlucoseThis study is being done to see if the blood pressure and metabolic effects of an approved drug nebivolol is comparable to that of another approved drug hydrochlorothiazide (HCTZ)…NCT00673790·Athens, Alabama and 87 others

CompletedA Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)The objective of this study is to evaluate the effects of sotatercept (MK-7962, formerly called ACE-011) treatment (plus maximum tolerated background pulmonary arterial…NCT04896008·Phoenix, Arizona and 56 others

CompletedEfficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionThis study is carried out to assess whether dapagliflozin lowers blood glucose, body weight and blood pressure, when added to patients existing medications and how it compares…NCT01031680·Gulf Shores, Alabama and 139 others

CompletedFREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multicenter, randomized (2:1 active:placebo), double-blind, placebo-controlled study in subjects with PAH who were NOT currently receiving…NCT00325403·Birmingham, Alabama and 76 others

CompletedA Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)The objectives of this study are to evaluate the efficacy and safety of sotatercept (MK-7962) treatment (plus background pulmonary arterial hypertension (PAH) therapy) versus…NCT04576988·Phoenix, Arizona and 119 others

CompletedPatiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)The purpose of this study is to assess the effects of patiromer compared with placebo on serum K+ in HF patients.NCT03888066·Alexander City, Alabama and 414 others

CompletedEfficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionThe purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with amlodipine in treating individuals with essential…NCT00591266·Mesa, Arizona and 49 others

CompletedPhase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral MonotherapyThis is an international, multicenter, randomized, double-blind, placebo-controlled, event driven study in subjects with pulmonary arterial hypertension.NCT01560624·Phoenix, Arizona and 154 others

CompletedA Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsStudy ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific…NCT03626688·Birmingham, Alabama and 208 others

CompletedClinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionThe main objective of the AC 055 303/SERAPHIN OL study, which will follow the AC 055 302/SERAPHIN study, will be to assess the long-term safety and tolerability of ACT 064992 in…NCT00667823·Birmingham, Alabama and 157 others

CompletedApproaches and Decisions for Acute Pediatric TBI TrialApproaches and Decisions in Acute Pediatric TBI Trial (ADAPT) is an international research study designed to evaluate the impact of interventions on the outcomes of children with…NCT04077411·Birmingham, Alabama and 47 others

TerminatedA Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial HypertensionStudy will assess PF-00489791 efficacy and safety in Pulmonary Arterial Hypertension (PAH)NCT00853112·Phoenix, Arizona and 24 others

CompletedStudy of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)To evaluate the change from baseline in pulmonary vascular resistance (PVR), and other hemodynamic parameters, following the addition of ambrisentan to background…NCT00617305·Mobile, Alabama and 29 others

Page 1 of 9Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia